When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning ...
Background Autosomal dominant Alzheimer’s disease (ADAD) serves as a model for presymptomatic biomarker discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results